Molecular Testing in Prostate Carcinoma

 

In line with all areas of molecular oncology, molecular testing has also expanded into the area of prostate carcinoma, providing insight into pathobiology of these tumors as well as significantly aiding in identifying diagnostic, prognostic and predictive biomarkers. Most recent guidelines from professional societies now include recommendations for relevant molecular testing in prostate carcinomas to complement the clinical practice. In this presentation, we will discuss relevant established and emerging standard of care molecular biomarkers in prostate carcinoma and the role pathologists can play in identifying clinically relevant molecular biomarkers.

Originally presented on February 7, 2023, in Park City, Utah.

Lecture Presenter

Deepika Sirohi, MD

Deepika Sirohi, MD

Former Assistant Professor
University of Utah School of Medicine
Former Medical Director, Solid FISH Pathology
ARUP Laboratories

Dr. Deepika Sirohi is a medical director of molecular oncology at ARUP Laboratories and an assistant professor at the University of Utah School of Medicine. Dr. Sirohi received her medical degree from the Armed Forces Medical College and then completed a residency in anatomic and clinical pathology at the University of Texas Health Science Center. She completed a genitourinary pathology fellowship at the Cedar-Sinai Medical Center and a molecular genetic pathology fellowship at the University of California. Dr. Sirohi is board certified in anatomic and clinical pathology and molecular genetic pathology. Her research interests include genomic alteration in urologic malignancies, viral oncogenesis, and applications of next generation sequencing to solid tumors.

Objectives

After this presentation, participants will be able to:

  • Review the standard-of-care molecular testing practices in prostate carcinoma
  • Outline the clinical necessity for molecular testing
  • Discuss emerging molecular tests on the horizon

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories